| pubmed-article:17225943 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17225943 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:17225943 | lifeskim:mentions | umls-concept:C0001792 | lld:lifeskim |
| pubmed-article:17225943 | lifeskim:mentions | umls-concept:C0007131 | lld:lifeskim |
| pubmed-article:17225943 | lifeskim:mentions | umls-concept:C0206135 | lld:lifeskim |
| pubmed-article:17225943 | lifeskim:mentions | umls-concept:C0078257 | lld:lifeskim |
| pubmed-article:17225943 | lifeskim:mentions | umls-concept:C0596545 | lld:lifeskim |
| pubmed-article:17225943 | lifeskim:mentions | umls-concept:C0205420 | lld:lifeskim |
| pubmed-article:17225943 | lifeskim:mentions | umls-concept:C0205187 | lld:lifeskim |
| pubmed-article:17225943 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:17225943 | pubmed:dateCreated | 2007-1-17 | lld:pubmed |
| pubmed-article:17225943 | pubmed:abstractText | Although poor-risk patients represent no minority in inoperable non-small cell lung cancer (NSCLC), there is little experience with concurrent radiochemotherapy (RCT) in this group. Here, the authors report on the feasibility and efficacy of RCT with vinorelbine plus carboplatin or cisplatin in NSCLC patients with comorbidities and poor general health or advanced age. | lld:pubmed |
| pubmed-article:17225943 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17225943 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17225943 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17225943 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17225943 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17225943 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17225943 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17225943 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:17225943 | pubmed:issn | 1439-099X | lld:pubmed |
| pubmed-article:17225943 | pubmed:author | pubmed-author:FietkauRainer... | lld:pubmed |
| pubmed-article:17225943 | pubmed:author | pubmed-author:VirchowChrist... | lld:pubmed |
| pubmed-article:17225943 | pubmed:author | pubmed-author:KlautkeGunthe... | lld:pubmed |
| pubmed-article:17225943 | pubmed:author | pubmed-author:SemrauSabineS | lld:pubmed |
| pubmed-article:17225943 | pubmed:author | pubmed-author:BierAnetteA | lld:pubmed |
| pubmed-article:17225943 | pubmed:author | pubmed-author:ThierbachUlri... | lld:pubmed |
| pubmed-article:17225943 | pubmed:author | pubmed-author:KettererPeter... | lld:pubmed |
| pubmed-article:17225943 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:17225943 | pubmed:volume | 183 | lld:pubmed |
| pubmed-article:17225943 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17225943 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17225943 | pubmed:pagination | 30-5 | lld:pubmed |
| pubmed-article:17225943 | pubmed:meshHeading | pubmed-meshheading:17225943... | lld:pubmed |
| pubmed-article:17225943 | pubmed:meshHeading | pubmed-meshheading:17225943... | lld:pubmed |
| pubmed-article:17225943 | pubmed:meshHeading | pubmed-meshheading:17225943... | lld:pubmed |
| pubmed-article:17225943 | pubmed:meshHeading | pubmed-meshheading:17225943... | lld:pubmed |
| pubmed-article:17225943 | pubmed:meshHeading | pubmed-meshheading:17225943... | lld:pubmed |
| pubmed-article:17225943 | pubmed:meshHeading | pubmed-meshheading:17225943... | lld:pubmed |
| pubmed-article:17225943 | pubmed:meshHeading | pubmed-meshheading:17225943... | lld:pubmed |
| pubmed-article:17225943 | pubmed:meshHeading | pubmed-meshheading:17225943... | lld:pubmed |
| pubmed-article:17225943 | pubmed:meshHeading | pubmed-meshheading:17225943... | lld:pubmed |
| pubmed-article:17225943 | pubmed:meshHeading | pubmed-meshheading:17225943... | lld:pubmed |
| pubmed-article:17225943 | pubmed:meshHeading | pubmed-meshheading:17225943... | lld:pubmed |
| pubmed-article:17225943 | pubmed:meshHeading | pubmed-meshheading:17225943... | lld:pubmed |
| pubmed-article:17225943 | pubmed:meshHeading | pubmed-meshheading:17225943... | lld:pubmed |
| pubmed-article:17225943 | pubmed:meshHeading | pubmed-meshheading:17225943... | lld:pubmed |
| pubmed-article:17225943 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17225943 | pubmed:articleTitle | 6-year experience of concurrent radiochemotherapy with vinorelbine plus a platinum compound in multimorbid or aged patients with inoperable non-small cell lung cancer. | lld:pubmed |
| pubmed-article:17225943 | pubmed:affiliation | Department of Radiotherapy, University of Rostock, Rostock, Germany. | lld:pubmed |
| pubmed-article:17225943 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17225943 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17225943 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17225943 | lld:pubmed |
